Literature DB >> 17239885

A long term experimental study of canine visceral leishmaniasis.

Alhelí Rodríguez-Cortés1, Ana Ojeda, Laura López-Fuertes, Marcos Timón, Laura Altet, Laia Solano-Gallego, Elisenda Sánchez-Robert, Olga Francino, Jordi Alberola.   

Abstract

Previous studies on Leishmania infantum and the canine immune response are derived mainly from short-term studies. To date, there have been no longitudinal studies that perform a serial analysis of the intensity of infection in conjunction with immunological parameters and clinical signs in Leishmania-infected dogs. For this purpose, six dogs were infected experimentally by the i.v. route and were monitored for 1 year. Clinical, immunological (humoral and cellular response) and parasitological (parasitaemia) parameters were evaluated monthly. Four dogs developed clinico-pathological signs compatible with leishmaniasis, whereas two dogs showed few abnormalities during the study. Evaluation of clinical, immunological and parasitological parameters showed that the intensity of Leishmania infection in blood samples, as indicated by the amount of Leishmania DNA, was correlated significantly with IgG, IgG1, IgG2, IgA, and IgM concentrations and with clinical signs. Parasitaemia and Leishmania-specific cell-mediated immunity were inversely correlated. Moreover, higher quantities of Leishmania DNA were detected in the liver, spleen, lymph node, skin and bone marrow of dogs exhibiting clinical signs than those exhibiting few such signs. These findings suggest that progressive disease in experimental canine leishmaniasis is associated with specific T-cell unresponsiveness and unprotective humoral responses which allow the dissemination and multiplication of L. infantum in different tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17239885     DOI: 10.1016/j.ijpara.2006.11.007

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  21 in total

1.  Immunohistochemical study of renal fibropoiesis associated with dogs naturally and experimentally infected with two different strains of Leishmania (L.) infantum.

Authors:  Adriano F Alves; Ramon A Pereira; Helida M de Andrade; David M Mosser; Wagner L Tafuri
Journal:  Int J Exp Pathol       Date:  2019-11-06       Impact factor: 1.925

2.  Semi-quantitative measurement of asymptomatic L. infantum infection and symptomatic visceral leishmaniasis in dogs using Dual-Path Platform® CVL.

Authors:  Mandy Larson; Angela Toepp; Benjamin Scott; Melissa Kurtz; Hailie Fowler; Javan Esfandiari; Randall F Howard; Aarthy C Vallur; Malcolm S Duthie; Christine Petersen
Journal:  Appl Microbiol Biotechnol       Date:  2016-10-31       Impact factor: 4.813

3.  Humoral and in vivo cellular immunity against the raw insect-derived recombinant Leishmania infantum antigens KMPII, TRYP, LACK, and papLe22 in dogs from an endemic area.

Authors:  Felicitat Todolí; Laia Solano-Gallego; Rafael de Juan; Pere Morell; Maria Del Carmen Núñez; Rodrigo Lasa; Silvia Gómez-Sebastián; José M Escribano; Jordi Alberola; Alhelí Rodríguez-Cortés
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

4.  Epidemiological implications of the use of various methods for the diagnosis of canine leishmaniasis in dogs with different characteristics and in differing prevalence scenarios.

Authors:  Manuel Morales-Yuste; Francisco Morillas-Márquez; Victoriano Díaz-Sáez; Sergio Barón-López; Carmen Acedo-Sánchez; Joaquina Martín-Sánchez
Journal:  Parasitol Res       Date:  2012-01-10       Impact factor: 2.289

5.  Leishmania infection: laboratory diagnosing in the absence of a "gold standard".

Authors:  Alhelí Rodríguez-Cortés; Ana Ojeda; Olga Francino; Laura López-Fuertes; Marcos Timón; Jordi Alberola
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

6.  Comparison of Leishmania OligoC-TesT PCR with conventional and real-time PCR for Diagnosis of canine Leishmania infection.

Authors:  Connor Carson; Rupert J Quinnell; Jennifer Holden; Lourdes M Garcez; Stijn Deborggraeve; Orin Courtenay
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

7.  Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis.

Authors:  A C Vallur; M S Duthie; C Reinhart; Y Tutterrow; S Hamano; K R H Bhaskar; R N Coler; D Mondal; S G Reed
Journal:  Clin Microbiol Infect       Date:  2013-11-18       Impact factor: 8.067

8.  Disseminated Leishmania infantum infection in two sibling foxhounds due to possible vertical transmission.

Authors:  Katherine N Gibson-Corley; Jesse M Hostetter; Shannon J Hostetter; Kathleen Mullin; Amanda E Ramer-Tait; Paola M Boggiatto; Christine A Petersen
Journal:  Can Vet J       Date:  2008-10       Impact factor: 1.008

9.  Assessment of the Effects of a Novel Herbal Immunomodulator Drug (IMOD) on Cytokine Profiles in Experimental Canine Visceral Leishmaniasis: a Preliminary Survey.

Authors:  Abdolali Malmasi; Bijan Ziaie Ardestani; Saeed Bayanolhagh; Mehdi Mohebali; Hamidreza Khorram Khorshid; Parisa Sadrpour; Negin Hosseini Rouzbahani; Behnaz Akhoundi; Soulmaz Naserli; Shadi Ziaie; Ehsan Mostafavi
Journal:  Iran J Parasitol       Date:  2014-09       Impact factor: 1.012

10.  Vaccines for canine leishmaniasis.

Authors:  Clarisa B Palatnik-de-Sousa
Journal:  Front Immunol       Date:  2012-04-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.